Guest guest Posted November 11, 2007 Report Share Posted November 11, 2007  News Business Sports Entertainment More... Classifieds NewsWatch Milwaukee Waukesha Ozaukee Washington Racine Wisconsin US/World Editorials Obituaries Traffic Weather News Business Sports Entertainment More... Classifieds News Investing Personal Finance Technology CareersAlso see: BusinessWatch E-Mail Newsletter News Business Sports Entertainment More... Classifieds Packers Brewers Bucks Badgers Marquette UWMPreps Golf Racing Hockey Soccer Outdoors | Also see: Packer Insider News Business Sports Entertainment More... Classifieds Dining Movies Music & Night Life Arts CalendarsBooks TV & Radio Puzzles & Comics Visitors' Guide News Business Sports Entertainment More... Classifieds Food & Cooking Health Lifestyle Travel Homes MultimediaSpecial Features Blogs Forums JSO Wireless Web Site Help News Business Sports Entertainment More... Classifieds Classifieds : Jobs Wheels Homes Rentals Pets Rummage StuffAlso see: Personals Milwaukee Marketplace Tickets Coupons Contests News Business Sports Entertainment More... Classifieds Journal Sentinel Newspaper Service CenterSubscribe to the Journal Sentinel | Manage Your Subscription Account | Make Us Your Home Page | Subscriptions Health, Fitness, Recreation, Health Columnists and Science NEWS Main Page Milwaukee Waukesha Washington Ozaukee Racine Wisconsin State Politics Editorials Education Watchdog Online » Watchdog Reports » Public Investigator » Citizen Watchdog » Data on Demand » No Quarter Traffic Obituaries SPORTS Main Page Packers/NFL Packer Insider Bucks/NBA Brewers/MLB Badgers » Football » Basketball Golden Eagles Panthers Preps Golf Outdoors Wave/Soccer Admirals/Hockey Racing BUSINESS Main Page News Economy Health care Investing Workplace More... ENTERTAINMENT EntertainmentMain Page Dining Movies Festivals Music andNightlife Performing Arts Visual Arts TV and Radio Books Calendars FEATURES Lifestyle Advice Columns Homes » Real Estate » Entreé Food/Cooking Personal Technology Health/Science Religion Cars Travel JS ONLINE: HEALTH & SCIENCE: E-MAIL | PRINTTHIS STORY Breast cancer survivors face another battle As patients live longer, they face heart complications caused by the cure By JOHN FAUBERjfauber@... Posted: Nov. 10, 2007 When Heun showed up at Froedtert Hospital last month, all she wanted was a second opinion on her breast cancer. Cancer Treatment Concerns Photo/Rick Wood At Froedtert Hospital in Wauwatosa, Heun reviews a test with cardiologist Choi this fall. She believes that a cancer drug was responsible for her going into heart failure. Quotable It's a reflection of success. They are surviving long enough to be at risk. - Jim ,an oncologist at the University of Wisconsin Hospital and Clinics in Madison Advertisement Buy a link here She wasn't expecting that heart doctors would get involved in her treatment. Heun, 58, collapsed and went into cardiac arrest at the Wauwatosa hospital while awaiting routine tests. She was revived, only to get disturbing news: Her heart was not pumping as well as it should, which might have been the result of the breast cancer treatments she received a couple of years earlier. "Now I'm going home with heart medication," Heun said while lying in her bed at the hospital, with her husband, Tom, sitting next to her. "I didn't come in with heart medication. Now we've got two problems." For years, physicians have known that some chemotherapy drugs and radiation can damage the heart. But doctors and patients have ratcheted up their concern as cancer patients live longer and as alternative therapies less toxic to the heart have become available. "In the old days, cardiac death (for cancer patients) was a blessing," said Byung-il Choi, a Froedtert cardiologist. "No more." Recent research published in the Journal of the American College of Cardiology suggested that breast cancer patients might be at even higher risk because of what's known as the "multiple-hit" hypothesis. The authors noted that physical inactivity and obesity - two independent risk factors for breast cancer and heart disease - are more common in breast cancer patients. Then, add in the various therapies breast cancer patients must go through. The result is a series of "cardiovascular insults," the authors wrote. The insults make the heart even more susceptible to injury and the patient more at risk of dying prematurely. Survivors at risk Heun's situation is complicated. Froedtert doctors say they do not think her cancer treatments led to the arrhythmia that caused her heart to stop. However, they found another problem with her heart that they do believe was caused by the cancer treatments. Her heart wasn't pumping efficiently. Cardiologists use a measure known as ejection fraction to describe how much blood is pumped out of the left ventricle, the heart's main pumping chamber, with each beat. A normal ejection fraction is 55% to 75%. Heun's ejection fraction is 35%, indicating damage to the heart muscle and a condition known as heart failure. "I knew that the chemotherapy and the radiation had something to do with this," said cardiologist Choi, who also is a professor of medicine at the Medical College of Wisconsin in Wauwatosa. Twenty-five years ago, Choi co-wrote a paper in the American Heart Journal highlighting the cardiovascular concerns of a particular cancer drug and offering recommendations on how and when it should be used to limit heart damage. Today, with 2.3 million American women living with a history of breast cancer and a 24% drop in the breast cancer death rate alone from 1990 to 2000, the concern is even more magnified. Quest for less-toxic drugs More and more doctors are looking to replace old-line cancer drugs that have known toxic heart effects with ones that might work as well but without the heart problems, said Jim , an oncologist at the University of Wisconsin Hospital and Clinics in Madison. "We have to assume that a woman with breast cancer will be alive 20 or 30 years later," said , also a professor of medicine at UW. Indeed, since aging is an independent risk factor for heart disease, longer survival for breast cancer patients who also might have been exposed to heart-damaging drugs is likely to mean more cases of cardiovascular disease in the years to come. "It's a reflection of success," said. "They are surviving long enough to be at risk." In September, a study of 43,338 older women treated for breast cancer between 1992 and 2002 found a 26% higher rate of subsequent heart failure in those treated with anthracycline cancer drugs compared with non-anthracycline drugs. Anthracyclines are a class of drugs used on a variety of cancers and still are a mainstay in breast cancer treatment. The research was published in the Journal of Clinical Oncology. Although anthracycline drugs are of more concern, most of the drugs used to treat breast cancer pose some short-term and long-term potential for heart complications, doctors say. Issues with radiation In March, a study in the Journal of the National Cancer Institute raised concerns about radiation therapy. The study noted that doctors have modified radiation therapy since the 1970s so that it is less harmful to the heart. However, it still can have an adverse effect on the heart, according to the study. The study involved 1,979 women who underwent radiation therapy of the internal mammary chain lymph nodes. They had higher rates of heart failure and heart valve dysfunction than those who received only breast irradiation. In addition, women who received radiation therapy and who smoked were three times more likely to have a heart attack. At some hospitals, oncologists now are using non-anthracycline drugs in selected breast cancer patients who already have heart problems that might be worsened by the drugs. Charlson, an oncologist at Froedtert and an assistant professor of medicine at the Medical College, pointed to recent preliminary research suggesting that another class of cancer drugs called taxanes might be less toxic to the heart than anthracyclines. As a result of that research, about 10% of breast cancer patients at Froedtert now are treated with the new drugs while doctors wait for more research to see if the drugs can be used in larger groups of breast cancer patients, he said. Already, some Internet-savvy patients are asking about other drug options because of concerns about heart damage, he said. A second chance at life The other good news is that by lifestyle changes and controlling other cardiovascular risk factors, cancer patients might be able to reduce their heart risk significantly, said Pamela , co-author of the paper last month in the Journal of the American College of Cardiology. That includes maintaining a healthy weight, exercising and being vigilant about controlling their blood pressure and cholesterol, said , a professor of cardiology at Duke University Medical Center in Durham, N.C. Indeed, she said the success of breast cancer treatment means doctors increasingly are telling patients two things: "Congratulations, you've been cured of cancer. Since you've been given a second chance at life, here's what you need to do to optimize it." In addition to radiation therapy and anthracycline drugs, the journal article noted other heart concerns associated with breast cancer treatment: • Another common breast cancer drug, Herceptin, is associated with a 2% to 4.1% increased incidence of heart failure. • Although endocrine therapy drugs such as tamoxifen are not known to be damaging to the heart (and might actually be beneficial for the heart), those drugs cause a small increase in formation of clots. • Promising new drugs that interfere with the blood supply to tumors might also increase the risk of clots, reduce the pumping ability of the heart and worsen high blood pressure. • At the same time, physical inactivity and weight gain can worsen heart problems for cancer patients. Some research suggests that breast cancer patients decrease their physical activity by two hours a week. Another study found that more than 70% of patients increased their body weight by 5 to 14 pounds. Other patients affected It's not just breast cancer patients who are at risk. In 1999, Sue Northey of lin underwent extensive radiation therapy for Hodgkin's disease, treatment that would damage her heart a few years later. Northey, 49, said she doesn't remember being told about the potential for heart problems, although things were such a blur and she was so worried about the cancer that any warnings might have slipped her mind. "How would I have made a different decision?" she added. "It was choosing between life and death, and I chose life." Her cancer has been in complete remission since 1999, but a few years ago the first signs of other problems started cropping up. She began feeling short of breath in 2004. "By the end I couldn't even walk up a flight of stairs," said Northey, an advertising executive. "I just didn't have any life anymore." Tests showed she had a condition known as constrictive pericarditis, a condition in which the pericardium, the sac around the heart, becomes inflamed, calcified and thick. A normal pericardium is about 1 to 3 millimeters thick; Northey's was between 5 and 8 millimeters. In July, Northey underwent a five-hour heart operation at Froedtert to remove scar tissue and part of the pericardium. Her shortness of breath has gone away, and she easily can walk for a half-hour on the treadmill. "I have a new lease on life," she said. "I feel the best I've felt in a decade." Her case, though, is an example of how cancer patients should be especially vigilant about taking care of their hearts because of the problems that can occur long after treatment, said Northey's doctor, Lee Biblo, a cardiologist at Froedtert. "It's like a chess game where you're trying to stay five or 10 years ahead," said Biblo, vice chairman of medicine at the Medical College. "In women, heart disease is still the number one killer." Buy a link here From the Nov. 11, 2007 editions of the Milwaukee Journal Sentinel Have an opinion on this story? Write a letter to the editor or start an online forum.Subscribe today and receive 4 weeks free! Sign up now. BACK TO TOP News | Business | Sports | Entertainment | Classifieds | Jobs | Wheels | Homes | Rentals XML/RSS News Feeds (What's this?) | JSO Wireless | Careers at the Journal Sentinel © 2005-2007, Journal Sentinel Inc. All rights reserved. | Produced by Journal Interactive | Privacy Policy Journal Sentinel Inc. is a subsidiary of Journal Communications. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.